Verdict: 4.5/5. Evonik VESTAKEEP PEEK M-Bead remains our recommended medical-grade implantable PEEK bead and powder for 2026 device programs. Consistently tight particle morphology, a serious implant-grade documentation package, and Evonik’s mature quality system outweigh the premium price — provided your engineering team budgets for powder-processing difficulty and a long qualification runway.
What It Actually Is
VESTAKEEP is Evonik’s polyether ether ketone franchise, and the M-Bead variant sits in the medical and implant corner of the portfolio, alongside molding and filament medical grades. Unlike standard extrusion pellets, M-Bead ships as fine spherical beads or powder engineered for processes where granulate is simply the wrong shape: porous surface coatings on spinal and trauma cages, sintered scaffolds, compression-molded semi-finished stock, and powder-bed fusion for patient-specific implants. The form factor is the whole point.
Bead Morphology and Why It Matters
In hands-on review the M-Bead form shows consistent particle-size distribution and genuinely spherical geometry. That consistency drives repeatable layer deposition in powder processes and uniform porous coatings when beads are sintered onto implant surfaces to encourage bony on-growth. Across the batches we reviewed, melt-viscosity stability was solid — exactly what you need when a validated process window cannot legally drift between lots.
Biocompatibility and the Documentation Bundle
This is where the resin earns its price tag. Implant-oriented VESTAKEEP grades run under a dedicated quality regime spanning traceability, formal change-control commitments, and ISO 10993 biocompatibility test packages that device makers need for regulatory submissions. Sourcing teams consistently cite the documentation — master files, batch certificates, and long-term supply agreements — as the reason they stay with Evonik or Invibio rather than gambling on cheaper industrial PEEK. For a Class III implant program, that paperwork is not a nice-to-have; it is the product.
Performance in Practice
Chemically this is still PEEK: a semi-crystalline polymer with glass transition around 143°C, melt near 343°C, tensile strength in the 90–100 MPa class for unfilled material, and elastic modulus in the 3–4 GPa range — close enough to cortical bone to ease the stress-shielding that plagues titanium. It is radiolucent, MRI-compatible, and survives repeated steam-sterilization cycles that degrade lesser thermoplastics. Fatigue and creep resistance under physiological loading are strong enough for demanding load-bearing scenarios, which is why PEEK keeps displacing metal in spinal and trauma hardware.
Process Reality
Powder-form PEEK is unforgiving. High processing temperatures, tight thermal management, and careful crystallinity control demand real engineering investment. Critically, bare PEEK is bioinert, not bioactive: it does not bond to bone on its own, which is precisely why porous coatings and hydroxyapatite-enhanced strategies exist. If your device needs osseointegration, budget for surface engineering on top of the resin cost. Minimum-order structures can also sting smaller device startups.
Against the Competition
The obvious benchmark is Invibio PEEK-OPTIMA, the incumbent with the deepest regulatory track record in spinal and trauma devices. Invibio still holds the edge in sheer predicate-device volume; Evonik counters with pricing pressure, reliable European supply, and an increasingly complete ecosystem including filament and powder forms for additive manufacturing. Victrex’s PEEK 450G is the industrial cousin — an excellent polymer, but not a substitute where implant-grade documentation is mandatory.
Who Should Buy
Buy M-Bead if you are building porous-coated, sintered, or powder-processed implantable devices and need bankable documentation behind every batch. Skip it — or at least downgrade — for non-implant, cost-sensitive medical parts where industrial PEEK or a domestic grade will do, and where no implant dossier is required.
Procurement Notes
Expect qualification timelines of 12–24 months for a new implantable program, so lock supply agreements early. Ask explicitly for the biocompatibility dossier scope, change-notification terms, and powder particle-size-distribution specs matched to your process window. In China, imported implant-grade PEEK still dominates registered device filings, though domestic producers are moving up the value chain — worth watching for cost leverage in non-implant medical applications.
Bottom Line
VESTAKEEP PEEK M-Bead is an infrastructure decision, not an impulse buy. For teams that need credible, repeatable, fully documented implantable PEEK powder, it delivers exactly what it promises. Score: 4.5/5 — docked half a point only for cost and the inherent process difficulty of powder-form PEEK.